Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 27, 2010 - Issue 8
388
Views
41
CrossRef citations to date
0
Altmetric
Research Article

DIURNAL, AGE, AND IMMUNE REGULATION OF INTERLEUKIN-1β AND INTERLEUKIN-1 TYPE 1 RECEPTOR IN THE MOUSE SUPRACHIASMATIC NUCLEUS

&
Pages 1546-1563 | Received 22 Jan 2010, Accepted 03 Jun 2010, Published online: 20 Sep 2010

REFERENCES

  • Beynon AL, Thome J, Coogan AN. (2009). Age and time of day influences on the expression of transforming growth factor-beta and phosphorylated SMAD3 in the mouse suprachiasmatic and paraventricular nuclei. Neuroimmunomodulation 16:392–399.
  • Breder CD, Dinarello CA, Saper CB. (1988). Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240:321–324.
  • Buttini M, Boddeke H. (1995). Peripheral lipopolysaccharide stimulation induces interleukin-1 beta messenger RNA in rat brain microglial cells. Neuroscience 65:523–530.
  • Cardell LO, Uddman R, Zhang Y, Adner M. (2008). Interleukin-1beta up-regulates tumor necrosis factor receptors in the mouse airways. Pulm. Pharmacol. Ther. 21:675–681.
  • Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T, Fontana A. (2007). TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc. Natl. Acad. Sci. U.S.A. 104:12843–12848.
  • Cayetanot F, Nygård M, Perret M, Kristensson K, Aujard F. (2009). Plasma levels of interferon-gamma correlate with age-related disturbances of circadian rhythms and survival in a non-human primate. Chronobiol. Int. 26:1587–1601.
  • Coogan AN, Wyse CA. (2008). Neuroimmunology of the circadian clock. Brain Res. 1232:104–112.
  • Dalm S, Enthoven L, Meijer OC, van der Mark MH, Karssen AM, de Kloet ER, Oitzl MS. (2005). Age-related changes in hypothalamic-pituitary-adrenal axis activity of male C57BL/6J mice. Neuroendocrinology 81:372–380.
  • Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9:46–56.
  • Diana A, Van Dam AM, Winblad B, Schultzberg M. (1999). Co-localization of interleukin-1 receptor type I and interleukin-1 receptor antagonist with vasopressin in magnocellular neurons of the paraventricular and supraoptic nuclei of the rat hypothalamus. Neuroscience 89:137–147.
  • Duguay D, Cermakian N (2009). The crosstalk between physiology and clock proteins. Chronobiol. Int. 26:1479–1513.
  • Ericsson A, Liu C, Hart RP, Sawchenko PE. (1995). Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 361:681–698.
  • Falk R, Hacham M, Nyska A, Foley JF, Domb AJ, Polacheck I. (2005). Induction of interleukin-1beta, tumour necrosis factor-alpha and apoptosis in mouse organs by amphotericin B is neutralized by conjugation with arabinogalactan. J. Antimicrob. Chemother. 55:713–720.
  • Ferri CC, Ferguson AV. (2003). Interleukin-1 beta depolarizes paraventricular nucleus parvocellular neurones. J. Neuroendocrinol. 15:126–133.
  • Fiedorowicz A, Figiel I, Zaremba M, Dzwonek K, Schliebs R, Oderfeld-Nowak B. (2008). Trimethyltin-evoked apoptosis of murine hippocampal granule neurons is accompanied by the expression of interleukin-1beta and interleukin-1 receptor antagonist in cells of ameboid phenotype, the majority of which are NG2-positive. Brain Res. Bull. 77:19–26.
  • French RA, VanHoy RW, Chizzonite R, Zachary JF, Dantzer R, Parnet P, Bluthé RM, Kelley KW. (1999). Expression and localization of pp80 and p68 interleukin-1 receptor proteins in the brain of adult mice. J. Neuroimmunol. 93:194–202.
  • Glezer I, Munhoz CD, Kawamoto EM, Marcourakis T, Avellar MC, Scavone C. (2003). MK-801 and 7-Ni attenuate the activation of brain NF-kappa B induced by LPS. Neuropharmacology 45:1120–1129.
  • Godbout JP, Johnson RW. (2006). Age and neuroinflammation: a lifetime of psychoneuroimmune consequences. Neurol. Clin. 24:521–538.
  • Guilding C, Piggins HD. (2007). Challenging the omnipotence of the suprachiasmatic timekeeper: are circadian oscillators present throughout the mammalian brain? Eur. J. Neurosci. 25:3195–3216.
  • Hagan P, Poole S, Bristow AF. (1993). Endotoxin-stimulated production of rat hypothalamic interleukin-1 beta in vivo and in vitro, measured by specific immunoradiometric assay. J. Mol. Endocrinol. 11:31–36.
  • Hammond EA, Smart D, Toulmond S, Suman-Chauhan N, Hughes J, Hall MD. (1999). The interleukin-1 type I receptor is expressed in human hypothalamus. Brain 122:1697–1707.
  • Hankins MW, Peirson SN, Foster RG. (2008). Melanopsin: an exciting photopigment. Trends Neurosci. 1:27–36.
  • Hassanain M, Bhatt S, Zalcman S, Siegel A. (2005). Potentiating role of interleukin-1beta (IL-1beta) and IL-1beta type 1 receptors in the medial hypothalamus in defensive rage behavior in the cat. Brain Res. 1048:1–11.
  • Hofman MA, Swaab DF. (2006). Living by the clock: the circadian pacemaker in older people. Ageing Res. Rev. 5:33–51.
  • Kalsbeek A, Palm IF, La Fleur SE, Scheer FA, Perreau-Lenz S, Ruiter M, Kreier F, Cailotto C, Buijs RM. (2006). SCN outputs and the hypothalamic balance of life. J. Biol. Rhythms 21:458–469.
  • Koyanagi S, Ohdo S. (2002). Alteration of intrinsic biological rhythms during interferon treatment and its possible mechanism. Mol. Pharmacol. 62:1393–1399.
  • Kwak Y, Lundkvist GB, Brask J, Davidson A, Menaker M, Kristensson K, Block, GD. (2008). Interferon-gamma alters electrical activity and clock gene expression in suprachiasmatic nucleus neurons. J. Biol. Rhythms 23:150–159.
  • Lechan RM, Toni R, Clark BD, Cannon JG, Shaw AR, Dinarello CA, Reichlin S. (1990). Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res. 514:135–140.
  • Leone MJ, Marpegan L, Bekinschtein TA, Costas MA, Golombek DA. (2006). Suprachiasmatic astrocytes as an interface for immune-circadian signalling. J. Neurosci. Res. 84:1521–1527.
  • Leone MJ, Chiesa JJ, Marpegan L, Golombek DA. (2007). A time to kill and a time to heal: pathophysiological interactions between the circadian and the immune systems. Physiol. Mini-Rev. 2:60–69.
  • Lucas SM, Rothwell NJ, Gibson R.M. (2006). The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147( Suppl 1):S232–S240.
  • Lundkvist GB, Robertson B, Mhlanga JD, Rottenberg ME, Kristensson, K. (1998). Expression of an oscillating interferon-gamma receptor in the suprachiasmatic nuclei. Neuroreport 9:1059–1063.
  • Lynch MA. (1998). Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1 beta? Prog. Neurobiol. 56:571–589.
  • Marpegán L, Bekinschtein TA, Costas MA, Golombek DA. (2005). Circadian responses to endotoxin treatment in mice. J. Neuroimmunol. 160:102–109.
  • Molenaar GJ, Berkenbosch F, van Dam AM, Lugard CM. (1993). Distribution of interleukin 1 beta immunoreactivity within the porcine hypothalamus. Brain Res. 608:169–174.
  • Moynagh PN. (2005) The NF-kappaB pathway. J. Cell Sci. 15:8589–8592.
  • Nygård M, Hill RH, Wikström MA, Kristensson K. (2005). Age-related changes in electrophysiological properties of the mouse suprachiasmatic nucleus in vitro. Brain Res. Bull. 65:149–154.
  • Nygård M, Lundkvist GB, Hill RH, Kristensson K. (2009). Rapid nitric oxide-dependent effects of tumor necrosis factor-alpha on suprachiasmatic nuclei neuronal activity. NeuroReport 20:213–217.
  • Portaluppi F, Touitou Y, Smolensky MH. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25:999–1016.
  • Quan N, Whiteside M, Herkenham M. (1998). Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 83:281–293.
  • Ross FM, Allan SM, Rothwell NJ, Verkhratsky A. (2003). A dual role for interleukin-1 in LTP in mouse hippocampal slices. J. Neuroimmunol. 144:61–67.
  • Schibler U. (2009). The 2008 Pittendrigh/Aschoff lecture: peripheral phase coordination in the mammalian circadian timing system. J. Biol. Rhythms 24:3–15.
  • Shaftel SS, Griffin WS, O'Banion MK. (2008). The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J. Neuroinflamm. 5:7.
  • van Dam AM, Poole S, Schultzberg M, Zavala F, Tilders FJ. (1998). Effects of peripheral administration of LPS on the expression of immunoreactive interleukin-1 alpha, beta, and receptor antagonist in rat brain. Ann. N. Y. Acad. Sci. 840:128–138.
  • Vitkovic L, Bockaert J, Jacque C. (2000). “Inflammatory” cytokines: neuromodulators in normal brain? J. Neurochem. 74:457–471.
  • Watanabe A, Shibata S, Watanabe S. (1995). Circadian rhythm of spontaneous neuronal activity in the suprachiasmatic nucleus of old hamster in vitro. Brain Res. 695:237–239.
  • Weinert D. (2000). Age-dependent changes of the circadian system. Chronobiol. Int. 17:261–283.
  • Yabuuchi K, Minami M, Katsumata S, Satoh M. (1994). Localization of type I interleukin-1 receptor mRNA in the rat brain. Brain Res. Mol. Brain Res. 27:27–36.
  • Yan HQ, Banos MA, Herregodts P, Hooghe R, Hooghe-Peters EL (1992). Expression of interleukin (IL)-1 beta, IL-6 and their respective receptors in the normal rat brain and after injury. Eur. J. Immunol. 22:2963–2971.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.